当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Norepinephrine 8mg added to D5W
HUMAN COMPOUNDED DRUG
72196-6057
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
8 mg/250 mL
72196-6057-1
Norepinephrine 4mg added to D5W
HUMAN COMPOUNDED DRUG
72196-6056
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
NOREPINEPHRINE BITARTRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 mg/250 mL
72196-6056-1
Heparin 2500units added to NS
HUMAN COMPOUNDED DRUG
72196-8100
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
HEPARIN SODIUM
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
2500 U/500 mL
72196-8100-1
ESTRADIOL 20MG
HUMAN COMPOUNDED DRUG
70713-145
Wells Pharmacy, Inc
2022/1/1 0:00:00
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg
70713-145-01
TESTOSTERONE C 200MG
HUMAN COMPOUNDED DRUG
70713-055
Wells Pharmacy, Inc
2022/1/1 0:00:00
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg
70713-055-01
PHENYLEPHRINE 1 MG ML 5 mL
HUMAN COMPOUNDED DRUG
70713-200
Wells Pharmacy, Inc
2022/1/1 0:00:00
PHENYLEPHRINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
70713-200-05
Papaverine HCL 30 mg Phentolamine Mesylate 3 mg Alprostradil 30 mcg Atropine Sulfate 0.1 mg
HUMAN COMPOUNDED DRUG
70713-203
Wells Pharmacy, Inc
2022/1/1 0:00:00
ALPROSTADIL; PHENTOLAMINE MESYLATE; PAPAVERINE HYDROCHLORIDE; ATROPINE SULFATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
30 ug/1 mL; 3 mg/1 mL; 30 mg/1 mL; .1 mg/1 mL
70713-203-06
Estradiol
HUMAN COMPOUNDED DRUG
70168-2100
BSO, LLC
2021/2/1 0:00:00
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg
70168-2100-1
Estradiol
HUMAN COMPOUNDED DRUG
70168-2060
BSO, LLC
2021/2/1 0:00:00
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg
70168-2060-1
Estradiol
HUMAN COMPOUNDED DRUG
70168-2090
BSO, LLC
2021/2/1 0:00:00
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
37.5 mg
70168-2090-1
Testosterone
HUMAN COMPOUNDED DRUG
70168-0102
BSO, LLC
2021/2/1 0:00:00
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg
70168-0102-1
Testosterone
HUMAN COMPOUNDED DRUG
70168-0124
BSO, LLC
2021/2/1 0:00:00
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg
70168-0124-1
Testosterone
HUMAN COMPOUNDED DRUG
70168-0125
BSO, LLC
2021/2/1 0:00:00
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
200 mg
70168-0125-1
Anastrozole
HUMAN COMPOUNDED DRUG
70168-0430
BSO, LLC
2021/2/1 0:00:00
ANASTROZOLE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 mg
70168-0430-1
Estradiol
HUMAN COMPOUNDED DRUG
70168-2050
BSO, LLC
2021/2/1 0:00:00
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
18 mg
70168-2050-1
Estradiol
HUMAN COMPOUNDED DRUG
70168-2030
BSO, LLC
2021/2/1 0:00:00
ESTRADIOL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
12.5 mg
70168-2030-1
Testosterone
HUMAN COMPOUNDED DRUG
70168-0100
BSO, LLC
2021/2/1 0:00:00
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg
70168-0100-1
Testosterone
HUMAN COMPOUNDED DRUG
70168-0060
BSO, LLC
2021/2/1 0:00:00
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
70 mg
70168-0060-1
Testosterone
HUMAN COMPOUNDED DRUG
70168-0041
BSO, LLC
2021/2/1 0:00:00
TESTOSTERONE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
50 mg
70168-0041-1
Testosterone/Anastrozole
HUMAN COMPOUNDED DRUG
70168-0510
BSO, LLC
2021/2/1 0:00:00
TESTOSTERONE; ANASTROZOLE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg; 4 mg
70168-0510-1
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3